fluorouracil has been researched along with Condition, Preneoplastic in 104 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of arsenical keratosis with multiple lesions of Bowen's disease and squamous cell carcinoma is described." | 7.72 | Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil. ( Khandpur, S; Sharma, VK, 2003) |
| "Three patients with biopsy-confirmed erythroplasia of Queyrat were treated with topically applied fluorouracil." | 7.65 | Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. ( DeVillez, RL; Elgart, M; Goette, DK, 1975) |
| " Rat skin was observed for erythema and edema and the formulation was found safe for chronic use (p˃0." | 5.42 | Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions. ( Kumar, S; Sinha, VR, 2015) |
| "We describe the successful treatment of porokeratosis of Mibelli of the left calf in an 83-year-old man with topical 5 percent imiquimod and topical 5 percent 5-fluorouracil." | 5.36 | Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ( LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D, 2010) |
| "Laser therapy appears the best option among nonsurgical approaches for actinic cheilitis, and PDT showed higher efficacy when sequentially combined with 5% imiquimod." | 5.05 | Treatments of actinic cheilitis: A systematic review of the literature. ( Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K, 2020) |
| "A case of arsenical keratosis with multiple lesions of Bowen's disease and squamous cell carcinoma is described." | 3.72 | Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil. ( Khandpur, S; Sharma, VK, 2003) |
| " Vitamin A acid and benzoyl peroxide have brought significant advances in the topical treatment of acne." | 3.66 | [Advances in topical therapy of skin diseases (author's transl)]. ( Happle, R, 1979) |
| "15 patients with superficial basaliomas or premalignant epithelial neoplastic disorders (actinic keratosis, leukoplakia, Bowen's disease) were treated locally over three weeks with retinoic acid (RA) alone or in combination with 5-fluorouracil (5-FU)." | 3.66 | [Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil]. ( Kurka, M; Orfanos, CE; Pullmann, H, 1978) |
| "Three patients with biopsy-confirmed erythroplasia of Queyrat were treated with topically applied fluorouracil." | 3.65 | Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. ( DeVillez, RL; Elgart, M; Goette, DK, 1975) |
| " Here, we investigated the efficacy of calcipotriol, a topical TSLP inducer, in combination with 5-fluorouracil (5-FU) as an immunotherapy for actinic keratosis." | 2.84 | Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. ( Cornelius, LA; Cunningham, TJ; Demehri, S; Eliane, JP; Kopan, R; Manivasagam, S; Mirzaalian, H; Saavedra, AP; Schaffer, A; Tabacchi, M; Tuchayi, SM; Turkoz, A; Wallendorf, M, 2017) |
| "In the future, the treatment of actinic keratosis can be more often done in primary health care." | 2.52 | [Diagnosis and treatment of actinic keratosis]. ( Isoherranen, K; Koskenmies, S; Overmark, M; Pitkänen, S; Saksela, O; Ylitalo, L, 2015) |
| "Actinic keratosis is a precancerous lesion that is commonly seen in the elderly patient and requires treatment." | 2.43 | [Actinic keratosis]. ( Dissemond, J; Grabbe, S, 2006) |
| "Actinic keratosis is currently believed to be an early stage in the evolution of squamous cell carcinoma." | 2.42 | Topical and light-based treatments for actinic keratoses. ( Alam, M; Goldberg, LH; Silapunt, S, 2003) |
| "The ability to manage non-melanoma skin cancers and pre-malignant lesions with topical pharmacologic agents is highly compelling." | 2.42 | Topical treatment strategies for non-melanoma skin cancer and precursor lesions. ( Fein, H; McGillis, ST, 2004) |
| "Actinic cheilitis is a common premalignant condition, significant for symptoms and potential development into invasive squamous cell carcinoma." | 2.40 | Actinic cheilitis. A treatment review. ( Curlin, MU; Dufresne, RG, 1997) |
| " Physiological information of treatment response derived via diffuse reflectance spectroscopy (DRS) from murine primary CRC tumors provide a better understanding for the development of new drugs and dosing strategies in CRC." | 1.56 | Diffuse reflectance spectroscopy to monitor murine colorectal tumor progression and therapeutic response. ( Bullard, EA; Fahr, MJ; Greening, GJ; Hale, LN; Muldoon, TJ; Mundo, AI; Rajaram, N, 2020) |
| "The cost of topical treatments for actinic keratosis (AK) has historically been evaluated in relation to the number of lesions requiring treatment or simply by the price of a single tube/sachet of the drug used." | 1.51 | Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions. ( Calzavara-Pinton, P; Hamon, P; Tanova, N, 2019) |
| " Rat skin was observed for erythema and edema and the formulation was found safe for chronic use (p˃0." | 1.42 | Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions. ( Kumar, S; Sinha, VR, 2015) |
| " DMH was given to fish by intraperitoneal injection in a dosage of 15 mg/kg body weight once a week for 6 weeks." | 1.37 | [Chemopreventive effects of 5-fluorouracil and lactoferrin on goldfish intestinal carcinogenesis induced by 1,2-dimethylhydrazine]. ( Kakuta, I; Takase, K, 2011) |
| "We describe the successful treatment of porokeratosis of Mibelli of the left calf in an 83-year-old man with topical 5 percent imiquimod and topical 5 percent 5-fluorouracil." | 1.36 | Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ( LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D, 2010) |
| "Final diagnosis stated a multilocular metastasising gastric cancer with infiltration of bone, peritoneum and dura and signet-cell infiltration of the bone marrow." | 1.31 | [Hemorrhagic diathesis as initial symptom of stomach carcinoma]. ( Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH, 2000) |
| "5-Fluorouracil was used at 3." | 1.30 | Destructive procedures are the standard of care for treatment of actinic keratoses. ( Feldman, SR; Fleischer, AB; Jorizzo, JL; Williford, PM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (56.73) | 18.7374 |
| 1990's | 6 (5.77) | 18.2507 |
| 2000's | 14 (13.46) | 29.6817 |
| 2010's | 22 (21.15) | 24.3611 |
| 2020's | 3 (2.88) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, M | 1 |
| Pampena, R | 1 |
| Cornacchia, L | 1 |
| Pellacani, G | 1 |
| Peris, K | 1 |
| Longo, C | 1 |
| Gupta, S | 2 |
| Jangra, RS | 1 |
| Gupta, SS | 1 |
| Gujrathi, AV | 1 |
| Mundo, AI | 1 |
| Greening, GJ | 1 |
| Fahr, MJ | 1 |
| Hale, LN | 1 |
| Bullard, EA | 1 |
| Rajaram, N | 1 |
| Muldoon, TJ | 1 |
| Walker, JL | 1 |
| Siegel, JA | 1 |
| Sachar, M | 1 |
| Pomerantz, H | 1 |
| Chen, SC | 1 |
| Swetter, SM | 1 |
| Dellavalle, RP | 1 |
| Stricklin, GP | 1 |
| Qureshi, AA | 1 |
| DiGiovanna, JJ | 1 |
| Weinstock, MA | 2 |
| Al-Haseni, A | 1 |
| Chitgopeker, P | 1 |
| Ho, JD | 1 |
| Goldberg, LJ | 1 |
| Sahni, D | 1 |
| Radyk, MD | 1 |
| Burclaff, J | 1 |
| Willet, SG | 1 |
| Mills, JC | 1 |
| Calzavara-Pinton, P | 1 |
| Tanova, N | 1 |
| Hamon, P | 1 |
| Routray, S | 1 |
| Dikhit, PS | 1 |
| Rajani, BC | 1 |
| Khan, MM | 1 |
| Beatson, M | 1 |
| Means, AD | 1 |
| Leader, NF | 1 |
| Robinson-Bostom, L | 1 |
| Samrao, A | 1 |
| Cockerell, CJ | 3 |
| Borycka-Kiciak, K | 1 |
| Białas, A | 1 |
| Wejman, J | 1 |
| Uchman-Musielak, M | 1 |
| Tarnowski, W | 1 |
| Isoherranen, K | 1 |
| Koskenmies, S | 1 |
| Overmark, M | 1 |
| Ylitalo, L | 1 |
| Saksela, O | 1 |
| Pitkänen, S | 1 |
| Kumar, S | 1 |
| Sinha, VR | 1 |
| Veloz-Martínez, MG | 1 |
| Quintana-Romero, V | 1 |
| Contreras-Morales, Mdel R | 1 |
| Jiménez-Vieyra, CR | 1 |
| Cunningham, TJ | 1 |
| Tabacchi, M | 1 |
| Eliane, JP | 1 |
| Tuchayi, SM | 1 |
| Manivasagam, S | 1 |
| Mirzaalian, H | 1 |
| Turkoz, A | 1 |
| Kopan, R | 1 |
| Schaffer, A | 1 |
| Saavedra, AP | 1 |
| Wallendorf, M | 1 |
| Cornelius, LA | 1 |
| Demehri, S | 1 |
| Endrizzi, BT | 1 |
| Lee, PK | 1 |
| Fenske, NA | 1 |
| Spencer, J | 1 |
| Adam, F | 1 |
| Terushkin, V | 1 |
| Braga, JC | 1 |
| Dusza, SW | 1 |
| Scope, A | 1 |
| Busam, K | 1 |
| Marghoob, AA | 1 |
| Gill, M | 1 |
| Halpern, AC | 1 |
| Shah, AY | 1 |
| Doherty, SD | 1 |
| Rosen, T | 2 |
| Venkatarajan, S | 1 |
| LeLeux, TM | 1 |
| Yang, D | 1 |
| Orengo, I | 1 |
| Takase, K | 1 |
| Kakuta, I | 1 |
| Jadotte, YT | 1 |
| Schwartz, RA | 2 |
| Fox, PA | 1 |
| Schmutz, JL | 1 |
| Trechot, P | 1 |
| Esmann, S | 1 |
| Jemec, GB | 1 |
| Robins, P | 1 |
| Gupta, AK | 1 |
| Tutrone, WD | 1 |
| Saini, R | 1 |
| Caglar, S | 1 |
| Weinberg, JM | 1 |
| Crespo, J | 1 |
| Marcus, L | 1 |
| Silapunt, S | 1 |
| Goldberg, LH | 1 |
| Alam, M | 1 |
| Khandpur, S | 1 |
| Sharma, VK | 1 |
| McGillis, ST | 1 |
| Fein, H | 1 |
| Sorio, C | 1 |
| Capelli, P | 1 |
| Lissandrini, D | 1 |
| Moore, PS | 1 |
| Balzarini, P | 1 |
| Falconi, M | 1 |
| Zamboni, G | 1 |
| Scarpa, A | 1 |
| Dissemond, J | 1 |
| Grabbe, S | 1 |
| Perrett, CM | 1 |
| McGregor, JM | 1 |
| Warwick, J | 1 |
| Karran, P | 1 |
| Leigh, IM | 1 |
| Proby, CM | 1 |
| Harwood, CA | 1 |
| Zide, MF | 1 |
| Borchard, F | 1 |
| Klein, E | 5 |
| Holtermann, OA | 1 |
| Helm, F | 3 |
| Milgrom, H | 3 |
| Stoll, HL | 3 |
| Rosner, D | 1 |
| Klein, LE | 1 |
| Burgess, G | 2 |
| Lin, PZ | 2 |
| Cai, HY | 1 |
| Shu, YJ | 1 |
| Wang, GQ | 1 |
| Wu, AR | 1 |
| Liu, SF | 1 |
| Li, MX | 1 |
| Dufresne, RG | 1 |
| Curlin, MU | 1 |
| Barnaby, JW | 1 |
| Styles, AR | 1 |
| Fowble, B | 1 |
| Hanlon, AL | 1 |
| Patchefsky, A | 1 |
| Freedman, G | 1 |
| Hoffman, JP | 1 |
| Sigurdson, ER | 1 |
| Goldstein, LJ | 1 |
| Pritchard, DM | 1 |
| Potten, CS | 1 |
| Hickman, JA | 1 |
| Feldman, SR | 1 |
| Fleischer, AB | 1 |
| Williford, PM | 1 |
| Jorizzo, JL | 1 |
| Evans, C | 1 |
| Dempke, W | 1 |
| von Poblozki, A | 1 |
| Kellner, O | 1 |
| Wolf, HH | 1 |
| Schmoll, HJ | 1 |
| Podzamczer, D | 1 |
| Miralles, P | 1 |
| La Calle Md, Md | 1 |
| Zarco, C | 1 |
| Berenguer, J | 1 |
| López Aldeguer, J | 1 |
| Valencia, E | 1 |
| Rubio, R | 1 |
| Ribera, JM | 1 |
| Katz, H | 1 |
| Redding, KG | 1 |
| Happle, R | 1 |
| Cullen, SI | 1 |
| Golden, GT | 1 |
| Rosenthal, JD | 1 |
| Shaw, A | 1 |
| Melski, JW | 1 |
| Kurka, M | 1 |
| Orfanos, CE | 1 |
| Pullmann, H | 1 |
| Goette, DK | 3 |
| Gartmann, H | 1 |
| Medina, D | 1 |
| Shepherd, F | 1 |
| Jansen, GT | 2 |
| Sturm, JT | 1 |
| Christenson, CE | 1 |
| Uecker, JH | 1 |
| Perry, JF | 1 |
| Elgart, M | 1 |
| DeVillez, RL | 1 |
| Levin, B | 1 |
| Karlin, DA | 1 |
| Schulman, S | 1 |
| Thorp, GW | 1 |
| Kirsner, JB | 1 |
| Rosenberg, IH | 1 |
| Poljacki, M | 1 |
| Stojanović, S | 1 |
| Svilar, V | 1 |
| de Keizer, RJ | 1 |
| de Wolff-Rouendaal, D | 1 |
| van Delft, JL | 1 |
| Hughes, RR | 1 |
| von Koppenfels, R | 1 |
| Müller, RP | 1 |
| Farah, FS | 1 |
| Shbaklo, Z | 1 |
| Lynch, PJ | 1 |
| Lowenfels, AB | 1 |
| Zala, L | 1 |
| Lapsa, RKh | 1 |
| Graham, JH | 1 |
| Helwig, EB | 1 |
| Dean, RE | 1 |
| Taylor, ES | 1 |
| Weisbrod, DM | 1 |
| Martin, JW | 1 |
| Riedel, B | 1 |
| Brosig, W | 1 |
| Nagel, R | 1 |
| Pust, R | 1 |
| Goto, M | 1 |
| Muramoto, S | 1 |
| Nakagaki, K | 1 |
| Zackheim, HS | 1 |
| Farber, EM | 1 |
| Miller, E | 1 |
| Walker, MJ | 1 |
| Trnka, J | 1 |
| Ott, F | 3 |
| Chevrel, B | 1 |
| Chevrel, JP | 1 |
| Storck, H | 2 |
| Eller, JJ | 1 |
| Epstein, E | 1 |
| Uthida-Tanaka, AM | 1 |
| Nakamura, S | 1 |
| de Britto-Costa, R | 1 |
| de Tavares Mello, E | 1 |
| Ebner, H | 1 |
| Williams, AC | 1 |
| Landes, E | 1 |
| Schuppli, R | 1 |
| Basset, A | 1 |
| Grosshans, E | 1 |
| Maleville, J | 1 |
| Eichenberger-De Beer, H | 1 |
| Achten, G | 1 |
| Van Oost, A | 1 |
| Ledoux-Corbusier, M | 1 |
| Midana, A | 1 |
| Leigheb, G | 1 |
| Llombart Bosch, M | 1 |
| Espinosa Cabañero, JA | 1 |
| Lewis, RJ | 1 |
| Bendl, BJ | 1 |
| Fulton, JE | 1 |
| Carter, DM | 1 |
| Hurley, HJ | 1 |
| Rossman, RE | 1 |
| Hueser, JN | 1 |
| Strand, ME | 1 |
| Pugh, RP | 1 |
| Weitgasser, H | 1 |
| Anderson, FE | 1 |
| Johnson, AM | 1 |
| Havyatt, MT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial[NCT00847912] | Phase 4 | 954 participants (Actual) | Interventional | 2009-06-26 | Completed | ||
| Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention: A Long-term (3 Years) Follow-up of Prospective, Randomized, Multicenter-clinical Trial[NCT03642535] | Phase 4 | 300 participants (Anticipated) | Interventional | 2018-08-30 | Recruiting | ||
| The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions[NCT02019355] | Early Phase 1 | 132 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Combination Topical 5-fluorouracil 5% / Calcipotriene 0.005% Cream for Treatment of in Situ and Superficially Invasive Squamous Cell Carcinoma of the Skin[NCT04839731] | Early Phase 1 | 30 participants (Anticipated) | Interventional | 2021-04-14 | Recruiting | ||
| Combination Calcipotriene 0.005% Foam and Fluorouracil 5% Cream for the Treatment of Actinic Keratoses on the Scalp[NCT03996252] | Early Phase 1 | 15 participants (Actual) | Interventional | 2019-07-01 | Terminated (stopped due to The study team was not able to start the study and they never completed the IRB submission, so the study was terminated.) | ||
| Calcipotriol Plus 5-Fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients[NCT04642287] | Phase 2 | 64 participants (Anticipated) | Interventional | 2026-01-31 | Not yet recruiting | ||
| Calcipotriol Plus 5-Flourouracil Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients[NCT04329221] | Phase 2 | 62 participants (Anticipated) | Interventional | 2026-01-01 | Not yet recruiting | ||
| Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860] | 560 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil[NCT02938715] | 26 participants (Actual) | Interventional | 2016-10-31 | Completed | |||
| Evaluation of Topical Application of 5% Imiquimod, 0.05% Imiquimod and 0.05% Nanoencapsulated Imiquimod Gel in the Treatment of Actinic Cheilitis: a Randomized Controlled Trial[NCT04219358] | Phase 1 | 49 participants (Actual) | Interventional | 2019-03-23 | Terminated (stopped due to Study terminated because of COVID19 pandemics.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00847912)
Timeframe: date of randomization to last visit before end of study follow up (6/30/2013), assessed up to four years
| Intervention | participants (Number) |
|---|---|
| Arm 1: 5-fluorouracil | 182 |
| Arm 2: Placebo, Vehicle Control | 177 |
Diagnosis of the first Primary Basil Cell Carcinoma (BCC) or primary Squamous Cell Carcinoma (SCC) on the face or ears that was removed surgically. (NCT00847912)
Timeframe: From randomization to last visit prior to end of study date (6/30/2013), assessed up to four years
| Intervention | years (Median) |
|---|---|
| Arm 1: 5-fluorouracil | 3.37 |
| Arm 2: Placebo, Vehicle Control | 3.52 |
18 reviews available for fluorouracil and Condition, Preneoplastic
| Article | Year |
|---|---|
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; D | 2020 |
Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
Topics: Administration, Topical; Aminoquinolines; Cryotherapy; Diclofenac; Dose-Response Relationship, Drug; | 2013 |
[Diagnosis and treatment of actinic keratosis].
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Ag | 2015 |
Actinic keratoses: past, present and future.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamou | 2010 |
Actinic cheilitis: a treatment review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Caustics; Cheilitis; Cryosurgery; | 2010 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cido | 2012 |
The use of topical fluorouracil to treat actinic keratosis.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Dermatologic Agents; Fluorouracil; Humans; | 2002 |
Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2003 |
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplasti | 2003 |
Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Ag | 2004 |
[Actinic keratosis].
Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineo | 2006 |
[The diffuse endocrine system and the carcinoids of the alimentary tract. Part I: Orthological aspects and common morphological features of the carcinoids (author's transl)].
Topics: Adrenocorticotropic Hormone; Aged; Appendiceal Neoplasms; APUD Cells; Carcinoid Tumor; Carmustine; C | 1982 |
Therapeutic perspectives in actinic and other keratoses.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Cryosurgery; Fluorouracil; Humans; Kerat | 1996 |
Actinic cheilitis. A treatment review.
Topics: Cheilitis; Cryosurgery; Electrocoagulation; Fluorouracil; Humans; Laser Therapy; Precancerous Condit | 1997 |
Actinic keratoses. Differential diagnosis and treatment.
Topics: Aging; Chemexfoliation; Combined Modality Therapy; Cryosurgery; Curettage; Dermabrasion; Diagnosis, | 1997 |
[Recommendations of GESIDA/Spanish National Plan of AIDS on diagnosis and treatment of Kaposi's sarcoma and cervical cancer in HIV-infected patients].
Topics: Acquired Immunodeficiency Syndrome; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agen | 2002 |
Review of erythroplasia of Queyrat and its treatment.
Topics: Adult; Aged; Erythroplasia; Fluorouracil; Humans; Male; Middle Aged; Penile Neoplasms; Precancerous | 1976 |
Topical antimetabolites.
Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Folic Acid Antagonists; | 1970 |
4 trials available for fluorouracil and Condition, Preneoplastic
| Article | Year |
|---|---|
Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
Topics: Administration, Topical; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; D | 2019 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Prot | 2017 |
Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Bowen's Disease | 2007 |
The effects of 5-fluorouracil (5-FU) ointment in the treatment of neoplastic dermatoses.
Topics: Clinical Trials as Topic; Fluorouracil; Humans; Neoplasm Metastasis; Ointments; Precancerous Conditi | 1970 |
82 other studies available for fluorouracil and Condition, Preneoplastic
| Article | Year |
|---|---|
A novel method to enhance efficacy of topical drugs by condom occlusion in penile dermatoses.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Balanitis; Condo | 2020 |
Diffuse reflectance spectroscopy to monitor murine colorectal tumor progression and therapeutic response.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Colorectal Neoplasms; Disease Models, A | 2020 |
5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Double | 2017 |
5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Double | 2017 |
5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Double | 2017 |
5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Double | 2017 |
Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: An unusual presentation leading to a novel therapeutic approach.
Topics: Administration, Cutaneous; Aged; Antimetabolites, Antineoplastic; Bandages; Biopsy; Cell Transformat | 2018 |
Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Cell Lineage; Cell Proliferation; Cell Transdifferentiat | 2018 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpene | 2019 |
Can topical 5-fluorouracil be used as a viable treatment option for oral premalignant lesions and tumors?
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Male; Precan | 2019 |
Perianal infection of highly oncogenic human papilloma virus: how to prevent from cancer? Case report.
Topics: Anal Canal; Anus Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Hemorrhoidectomy; He | 2015 |
Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relatio | 2015 |
[Treatment results for different categories of vaginal intraepithelial neoplasia with electrocoagulation, 5-fluorouracil and combined treatment].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squam | 2015 |
Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorourac | 2009 |
Over the last several years, I've had several small spots of skin on my shoulder cut out due to skin cancer concerns. Now, my doctor say I have precancerous areas on my face that need treatment, but he's recommending I use a cream. Is that likely to wor
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Face; Fluorouracil; Humans; Precancerous C | 2010 |
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curet | 2010 |
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cel | 2010 |
[Chemopreventive effects of 5-fluorouracil and lactoferrin on goldfish intestinal carcinogenesis induced by 1,2-dimethylhydrazine].
Topics: 1,2-Dimethylhydrazine; Animals; Anti-Infective Agents; Antimetabolites, Antineoplastic; Blood Cell C | 2011 |
Solar cheilosis: an ominous precursor part II. Therapeutic perspectives.
Topics: Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Squamous Cell; Cheilitis; Combined Moda | 2012 |
[Resolution of actinic keratosis with capecetabin].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorou | 2012 |
Patients' perceptions of topical treatments of actinic keratosis.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Diclofenac | 2014 |
Photodynamic therapy for actinic keratosis followed by 5-fluorouracil reaction.
Topics: Aminolevulinic Acid; Antimetabolites, Antineoplastic; Emollients; Female; Fluorouracil; Humans; Kera | 2003 |
Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil.
Topics: Acitretin; Arsenic; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Drug Therapy, Combina | 2003 |
Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion.
Topics: Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cystadenocarcinoma, Mucinous; Disease Models | 2005 |
Actinic keratosis: from the skin to the lip.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Chemexfoliation; Cryosurgery; Elec | 2008 |
Topical therapy for cutaneous tumors.
Topics: Administration, Topical; Antineoplastic Agents; Fluorouracil; Humans; Hypersensitivity; Immunotherap | 1984 |
[Treatment of marked epithelial dysplasia of esophagus. II. Microspectophotometric studies on DNA content in epithelial cells of esophagus treated with antitumor B III or tilorone (author's transl)].
Topics: Antineoplastic Agents, Phytogenic; DNA, Neoplasm; Drug Combinations; Drugs, Chinese Herbal; Epitheli | 1981 |
[Therapy of severe epithelial dysplasia of esophagus. I. Therapeutic effects of Antitumor B III, Antitumor B and tilorone (author's transl)].
Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Drug Combinations; Drugs, Chinese Herbal; Esophag | 1980 |
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neopl | 1998 |
The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Division; Colon; Cyclin-Dependent Kinase I | 1998 |
Destructive procedures are the standard of care for treatment of actinic keratoses.
Topics: Antimetabolites, Antineoplastic; Florida; Fluorouracil; Health Care Surveys; Humans; Keratosis; Medi | 1999 |
Actinic keratosis: time to call a spade a spade.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Epidermis; Fluorouracil; Humans; Keratino | 2000 |
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplasti | 2000 |
Therapeutic challenge of premalignant and malignant skin lesions.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Aged; Balanitis; Bowen's Disease; Clioquinol; Cryosurgery; | 1975 |
[Advances in topical therapy of skin diseases (author's transl)].
Topics: Acne Vulgaris; Administration, Topical; Alopecia; Benzoyl Peroxide; Dinitrochlorobenzene; Fluocortol | 1979 |
Topical fluorouracil therapy for precancers and cancers of the skin.
Topics: Administration, Topical; Drug Eruptions; Fluorouracil; Humans; Keratosis; Precancerous Conditions; S | 1979 |
Carcinoma of the rectum in adolescence.
Topics: Adenocarcinoma, Mucinous; Adolescent; Age Factors; Cyclophosphamide; Fluorouracil; Humans; Hydroneph | 1975 |
Surgical treatment of erythroplasia of Queyrat.
Topics: Erythroplasia; Fluorouracil; Humans; Male; Precancerous Conditions | 1978 |
[Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil].
Topics: Aged; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Keratosis; Leu | 1978 |
[Topical use of antineoplastic agents in precancerous conditions of the skin].
Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Kera | 1977 |
Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Female; Fluorouracil; Mammary Neoplasms, Experimen | 1977 |
Practical therapy for hyperkeratotic skin lesions.
Topics: Acetates; Aged; Bandages; Callosities; Electrosurgery; Female; Fluorouracil; Foot; Humans; Keratoaca | 1975 |
Squamous-cell carcinoma of the anus arising in a giant condyloma acuminatum: report of a case.
Topics: Administration, Topical; Anal Canal; Anus Diseases; Anus Neoplasms; Carcinoma, Squamous Cell; Condyl | 1975 |
Erythroplasia of Queyrat. Treatment with topically applied fluorouracil.
Topics: Administration, Topical; Aged; Biopsy; Erythroplasia; Fluorouracil; Humans; Male; Middle Aged; Penil | 1975 |
The gasteointestinal oncology clinic. A multidisciplinary approach to cancer diagnosis and management at a University Medical Center.
Topics: Adenocarcinoma; Colitis, Ulcerative; Colonic Neoplasms; Cyclophosphamide; Drug Therapy, Combination; | 1976 |
[The importance of local administration of 5% 5-fluorouracil in the therapy of senile keratoses and basocellular carcinoma].
Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Male; | 1989 |
Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.
Topics: Aged; Carcinoma in Situ; Conjunctival Diseases; Corneal Diseases; Drug Administration Schedule; Eyel | 1986 |
Early diagnosis and management of premalignant lesions and early invasive cancers of the vulva.
Topics: Adult; Aged; Carcinoma; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metas | 1971 |
[Clinical picture and radiotherapy of malignant vulvar neoplasms].
Topics: Adult; Age Factors; Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middle A | 1973 |
The treatment of premalignant and malignant skin lesions with 5-fluorouracil.
Topics: Drug Eruptions; Female; Fluorouracil; Humans; Keratosis; Male; Precancerous Conditions; Skin; Skin N | 1971 |
Tumors of the skin. Premalignment and malignant.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Kera | 1974 |
Local chemotherapy of skin cancer.
Topics: Administration, Topical; Fluorouracil; Humans; Precancerous Conditions; Skin Neoplasms | 1974 |
[Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middl | 1972 |
[The reactivity of the RES in cancer of the gastrointestinal tract and during treatment with fluorofur].
Topics: Achlorhydria; Adult; Aged; Colonic Neoplasms; Esophageal Neoplasms; Female; Fluorouracil; Furans; Go | 1972 |
Erythroplasia of Queyrat. A clinicopathologic and histochemical study.
Topics: Adult; Age Factors; Aged; Biopsy; Erythroplasia; Ethnicity; Female; Fluorouracil; Histocytochemistry | 1973 |
Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
Topics: Administration, Topical; Antigens, Bacterial; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinom | 1972 |
Letter: Erythroplasia of Queyrat.
Topics: Erythroplasia; Fluorouracil; Humans; Precancerous Conditions | 1974 |
The treatment of premalignant and malignant lesions of the vulva.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluoroura | 1974 |
[Preoperative treatment of the carcinoma of the urinary bladder (author's transl)].
Topics: Bone Marrow; Cystitis; Diarrhea; Fluorouracil; Humans; Precancerous Conditions; Preoperative Care; R | 1974 |
[Experience with 5-fluorouracil in malignant skin tumors].
Topics: Adult; Aged; Female; Fluorouracil; Humans; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Male | 1967 |
Topical therapy with 5-Fluorouracil.
Topics: DNA; Fluorouracil; Humans; Keratosis; Pharmaceutical Vehicles; Precancerous Conditions; Propylene Gl | 1971 |
Tumors of the skin. XII. Topical 5-Fluorouracil for epidermal neoplasms.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Esthetics; Female; Fluorouracil; Humans | 1971 |
[Topical therapy of superficial basalioma and senile keratoma with 5-fluorouracil].
Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Precancerous Conditions; Skin Neoplasm | 1971 |
[Trials using local 5-FU therapy in precancerous states and cancer of the skin].
Topics: Carcinoma, Basal Cell; Fluorouracil; Follow-Up Studies; Humans; Keratosis; Ointments; Precancerous C | 1971 |
[Gallbladder cancer].
Topics: Adenocarcinoma; Adenoma; Carcinoma; Cholelithiasis; Fluorouracil; Gallbladder Neoplasms; Humans; Mel | 1971 |
[5-Fluorouracil in local therapy of precancerous conditions and carcinoma of the skin].
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratosis; Neoplasm Recurrenc | 1971 |
Topical fluorouracil (5-FU) for premalignant keratoses.
Topics: Fluorouracil; Humans; Keratosis; Precancerous Conditions | 1971 |
Cancer and precancer of the skin, review of 40 years experience in therapy.
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Methods; Precancerous Conditions; Radiotherapy Dosag | 1971 |
Treatment of precancerous dermatoses with topical 5-Fluorouracil.
Topics: Fluorouracil; Humans; Keratosis; Ointments; Precancerous Conditions; Skin Diseases; Solutions | 1969 |
[Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fluorouracil | 1969 |
[New possibilities in the treatment of epithelioma].
Topics: Animals; Fluorouracil; Humans; Precancerous Conditions; Rats; Skin Neoplasms; Thymine; Uracil | 1969 |
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions.
Topics: Antigen-Antibody Reactions; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Dermatitis, | 1970 |
[Treatment of carcinoma and precancerosis using 5-fluorouracil].
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Occlusive Dressings | 1970 |
[Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Topics: Antineoplastic Agents; Azathioprine; Condylomata Acuminata; Fluorouracil; Humans; Immunosuppressive | 1970 |
[Our experience with the local chemotherapy of cutaneous precancerous conditions, epithelioma and of kerato-acanthoma].
Topics: Colchicine; Diagnosis, Differential; Fluorouracil; Humans; Keratoacanthoma; Ointments; Precancerous | 1970 |
The local treatment of precancerous skin conditions with 5-fluorouracil ointment.
Topics: Fluorouracil; Humans; Ointments; Precancerous Conditions; Skin Neoplasms; Time Factors | 1970 |
5-fluorouracil (5-FU) ointment in the treatment of basal cell epithelioma. Histological control over a long duration.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Male; Middle Ag | 1970 |
5-fluorouracil (5-FU) ointment in the treatment of benign and malignant skin lesions.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; L | 1970 |
Preliminary experience with 5-fluorouracil ointment in the treatment of neoplasias and precancerous lesions of the skin.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Neoplasm Metast | 1970 |
Erythroplasia of Queyrat: repor. of a patient successfully treated with topical 5-fluorouracil.
Topics: Adult; Drug Hypersensitivity; Erythroplasia; Fluorouracil; Humans; Male; Penile Diseases; Precancero | 1971 |
Treatment of Bowen's disease with topical 5-fluorouracil under occlusion.
Topics: Aged; Carcinoma, Squamous Cell; Fluorouracil; Humans; Precancerous Conditions; Skin Neoplasms; Thigh | 1968 |
Topical chemotherapy of precancerous dermatoses.
Topics: Fluorouracil; Humans; Keratosis; Precancerous Conditions | 1968 |
Topical 5-fluorouracil in the treatment of actinic keratoses.
Topics: Aged; Fluorouracil; Humans; Keratosis; Male; Neoplasms, Radiation-Induced; Precancerous Conditions; | 1968 |
[Experiences with a cytostaticly active ointment in the dermatologic practice. (5 per cent--5-fluorouracil ointment)].
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Lichen P | 1969 |
Preliminary studies in the use of 5-fluoro-uracil cream in the treatment of malignant and premalignant skin tumours.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; O | 1969 |